FDA Threatens 2 Device Makers, 1 Fish Processor for Violations of CGMP & HACCP
The Food and Drug Administration issued warning letters to two medical device manufacturers in Germany and China, respectively, as well as a fish and fishery product processor in the Philippines, threatening detention without physical examination and/or refusal of future device…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
applications. Ningbo Huahui Medical Instruments Company Limited (here), of China, and Leisegang Feinmechanik-Optik GmbH (here), of Germany, were cited for violations of current good manufacturing processes in their medical device manufacturing. Huahui was threatened with detention without physical examination if the violations are not corrected, and the FDA told Leisengang that its premarket license applications for Class III devices would not be approved. The FDA also told Philippine fish processor Well -- Delight Network Corporation (here) that its products may be detained unless it revises its Hazard Analysis & Critical Control Points (HACCP) plan.